Usefulness of atherogenic index of plasma for estimating reduced eGFR risk: insights from the national health and nutrition examination survey

References

• Webster A, Nagler E, Morton R, et al. Chronic kidney disease. Lancet. 2017;389:1238–1252.
   PubMed Web of Science ®Google Scholar
• Nugent R, Fathima S, Feigl A, et al. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract. 2011;118:c269–77.
   PubMedGoogle Scholar
• Ayodele O, Alebiosu C. Burden of chronic kidney disease: an international perspective. Adv Chronic Kidney Dis. 2010;17:215–224.
   PubMed Web of Science ®Google Scholar
• Levey A, Astor B, Stevens L, et al. Chronic kidney disease, diabetes, and hypertension: what’s in a name? Kidney Int. 2010;78:19–22.
   PubMed Web of Science ®Google Scholar
• Horowitz B, Miskulin D, Zager P. Epidemiology of hypertension in CKD. Adv Chronic Kidney Dis. 2015;22:88–95.
   PubMed Web of Science ®Google Scholar
• Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama study. Kidney Int. 2005;68:228–236.
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Navab M, Fogelman AM. HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol. 2010;6:287–296.
   PubMed Web of Science ®Google Scholar
• Dominguez JH, Tang N, Xu W, et al. Studies of renal injury III: lipid-induced nephropathy in type II diabetes. Kidney Int. 2000;57:92–104.
   PubMed Web of Science ®Google Scholar
• Coll B, Betriu A, Martinez-Alonso M, et al. Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: usefulness of non-invasive tests in cardiovascular assessment. Nephrol Dial Transplant. 2010;25:3017–3025.
   PubMed Web of Science ®Google Scholar
• Cho I, Min HS, Chun EJ, et al. Coronary atherosclerosis detected by coronary CT angiography in asymptomatic subjects with early chronic kidney disease. Atherosclerosis. 2010;208:406–411.
   PubMed Web of Science ®Google Scholar
• Magil A. Interstitial foam cells and oxidized lipoprotein in human glomerular disease. Mod Pathol. 1999;12:33–40.
   PubMed Web of Science ®Google Scholar
• Lee HS, Kim YS. Identification of oxidized low density lipoprotein in human renal biopsies. Kidney Int. 1998;54:848–856.
   PubMed Web of Science ®Google Scholar
• Dobiásová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34:583–588.
   PubMed Web of Science ®Google Scholar
• Wu TT, Gao Y, Zheng YY, et al. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 2018;17:197.
   PubMed Web of Science ®Google Scholar
• Choudhary MK, Eräranta A, Koskela J, et al. Atherogenic index of plasma is related to arterial stiffness but not to blood pressure in normotensive and never-treated hypertensive subjects. Blood Press. 2019;28:157–167.
   PubMed Web of Science ®Google Scholar
• Chang Y, Li Y, Guo X, et al. Atherogenic index of plasma predicts hyperuricemia in rural population: a cross-sectional study from Northeast China. Int J Environ Res Public Health. 2016;13(9):879.
   Web of Science ®Google Scholar
• Shen S, Lu Y, Qi H, et al. Association between ideal cardiovascular health and the atherogenic index of plasma. Medicine (Baltimore). 2016;95:e3866.
   PubMed Web of Science ®Google Scholar
• Levey A, Stevens L, Schmid C, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815–822.
   PubMed Web of Science ®Google Scholar
• Chobanian A, Bakris G, Black H, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Classification and Diagnosis of Diabetes. Diabetes Care. 2018;41:S13–S27.
   PubMed Web of Science ®Google Scholar
• Shen SW, Lu Y, Li F, et al. Atherogenic index of plasma is an effective index for estimating abdominal obesity. Lipids Health Dis. 2018;17:11.
   PubMed Web of Science ®Google Scholar
• Guelker JE, Bufe A, Blockhaus C, et al. The atherogenic index of plasma and its impact on recanalization of chronic total occlusion. Cardiol J. 2018. [Epub online ahead of print].
   PubMed Web of Science ®Google Scholar
• Bendzala M, Sabaka P, Caprnda M, et al. Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women: A 10-year follow-up. Wien Klin Wochenschr. 2017;129:793–798.
   PubMed Web of Science ®Google Scholar
• Cook NR. Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction. Circulation. 2007;115:928–935.
   PubMed Web of Science ®Google Scholar
• Pickering JW, Endre ZH. New metrics for assessing diagnostic potential of candidate biomarkers. Clin J Am Soc Nephrol. 2012;7:1355–1364.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’ Agostino RB, D’ Agostino RB, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172.
   PubMed Web of Science ®Google Scholar
• Pencina M, D’Agostino R, Steyerberg E. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11–21.
   PubMed Web of Science ®Google Scholar
• Grunkemeier GL, Jin R. Net reclassification index: measuring the incremental value of adding a new risk factor to an existing risk model. Ann Thorac Surg. 2015;99:388–392.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Hu JW, Wang Y, et al. Association between atherogenic index of plasma and subclinical renal damage over a 12-year follow-up: hanzhong adolescent hypertension study. Eur J Clin Nutr. 2020;74:278–284.
   PubMed Web of Science ®Google Scholar
• Hager M, Narla A, Tannock L. Dyslipidemia in patients with chronic kidney disease. Rev Endocr Metab Disord. 2017;18:29–40.
   PubMed Web of Science ®Google Scholar
• Hou X, Wang C, Zhang X, et al. Triglyceride levels are closely associated with mild declines in estimated glomerular filtration rates in middle-aged and elderly Chinese with normal serum lipid levels. PLoS One. 2014;9:e106778.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Furusyo N, Mitsumoto F, et al. Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: results from the Kyushu and Okinawa Population Study (KOPS). Atherosclerosis. 2015;238:207–212.
   PubMed Web of Science ®Google Scholar
• Tozawa M, Iseki K, Iseki C, et al. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int. 2002;62:1743–1749.
   PubMed Web of Science ®Google Scholar
• Lanktree MB, Thériault S, Walsh M, et al. Triglycerides as risk factors for CKD: a mendelian randomization study. Am J Kidney Dis. 2018;71:166–172.
   PubMed Web of Science ®Google Scholar
• Vaziri N. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease. J Ren Nutr. 2010;20:S35–43.
   PubMed Web of Science ®Google Scholar
• Hara S, Kobayashi N, Sakamoto K, et al. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis. Am J Pathol. 2015;185:2118–2131.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Kobayashi T, Kamata K. Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem. 2007;14:3209–3220.
   PubMed Web of Science ®Google Scholar
• Saito T, Ootaka T, Sato H, et al. Participation of macrophages in segmental endocapillary proliferation preceding focal glomerular sclerosis. J Pathol. 1993;170:179–185.
   PubMed Web of Science ®Google Scholar
• Hattori M, Horita S, Yoshioka T, et al. Mesangial phenotypic changes associated with cellular lesions in primary focal segmental glomerulosclerosis. Am J Kidney Dis. 1997;30:632–638.
   PubMed Web of Science ®Google Scholar
• Abrass C. Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol. 2004;24:46–53.
   PubMed Web of Science ®Google Scholar